Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-02-25FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination by Sandoz Inc.
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Mapping Functional Networks of Brain Activity Using EEG in Patients With Essential Tremor or Parkinson Disease Before and After MR-guided Focused Ultrasound Thalamotomy for Tremor
This clinical trial update describes EEG-based mapping of brain networks in patients with essential tremor or Parkinson disease before and a…
-
CLINICAL_TRIALS withdrawal · 2016-02-25Clinical Trial Update: Characterizing the Specificity and Stability of Local Field Potentials in the Globus Pallidus Internus of Patients Undergoing Deep Brain Stimulation for Parkinson's Disease [Phase 1]
Phase 1 clinical trial evaluating the specificity and stability of local field potentials in the globus pallidus internus during deep brain …
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: LFP Correlates of Movement Disorders [NA]
This clinical trial update discusses LFP correlates of movement disorders (Parkinson's disease), sponsored by Colorado Neurological Institut…
-
FDA approval · 2016-02-22FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the combination product carbidopa, levodopa, and entacapone (Sandoz), expanding the regulatory a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-02-22FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for entacapone submitted by Sun Pharmaceutical Industries, Inc. The approval updates the drug’s labe…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease [Phase 3]
Phase 3 trial update for IPX066 in Parkinson's disease; results posted in 2016.
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Effect of a Lipidic and Proteic Controlled Diet on Parkinson's Disease [NA]
Clinical trial update on the effects of a lipidic and proteic controlled diet for Parkinson disease; the status and phase are not specified.
-
FDA approval · 2016-02-18FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Sandoz Inc.'s carbidopa/levodopa/entacapone product. It is used to treat Parkinson's disease…
-
FDA approval · 2016-02-17FDA Approved: CARBIDOPA — Original Application (Edenbridge Pharmaceuticals LLC.)
FDA approved Edenbridge Pharmaceuticals LLC's Original Application for a generic carbidopa product. The drug is used to treat Parkinson dise…
-
FDA approval · 2016-02-15FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental Abbreviated New Drug Application for Teva's generic carbidopa/levodopa. The product is a standard treatment for …
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938) [Phase 3]
Phase 3 trial of preladenant in moderate to severe Parkinson's disease completed with results posted.
-
CLINICAL_TRIALS research · 2016-02-11Clinical Trial Update: Safety Study to Autonomic Rehabilitation o Parkinson's Disease [NA]
Update on a completed clinical trial evaluating autonomic rehabilitation in Parkinson disease. The snippet notes the study status as complet…
-
CLINICAL_TRIALS research · 2016-02-10Clinical Trial Update: Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI [NA]
A terminated clinical trial evaluating the neurocognitive effects of bilateral subthalamic nucleus versus globus pallidus internus deep brai…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Trodat 1 SPECT and Dopamine Polymorphism
Clinical trial NCT01381302 evaluating Trodat 1 SPECT imaging and dopamine polymorphism in Parkinson disease has completed.
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Parkinson Disease Before and After Medication and Rehabilitation Treatment [NA]
This entry reports an ongoing clinical trial evaluating Parkinson disease outcomes before and after medication and rehabilitation treatment.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Effects of Virtual Reality Based Training on Posture Stability in Parkinson's Disease [NA]
A completed clinical trial evaluating the effects of virtual reality-based training on posture stability in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Tango for Treatment of Motor and Non-motor Manifestations in Parkinson's Disease. [EARLY_Phase 1]
An early Phase 1 trial evaluating Tango for motor and non-motor symptoms of Parkinson's disease has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
Clinical trial update indicating completion and posted results of a study investigating imaging biomarkers of progression of mobility impair…
-
FDA approval · 2016-01-29FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy
The PIRLONG-PD trial evaluating piribedil in Parkinson's disease during long-term therapy has completed. The update summarizes the safety an…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease [NA]
A clinical trial investigating the effects of exercise on Parkinson's disease, with the current status not specified.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Consolidation of Motor Learning of Writing Skills and Its Related Brain Activity Changes in Parkinson's Disease [NA]
This entry reports the completion of a KU Leuven-led clinical trial examining consolidation of motor learning of writing skills and the asso…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD [Phase 1, Phase 2]
A Phase 1/2 trial assessing tolerability of repeat intracerebroventricular administration of sNN0031 infusion solution in Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031. [Phase 1]
A Phase 1 study in Parkinson's disease investigating an increased dose step in patients who previously received placebo or the investigation…